{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:59:48Z","timestamp":1788821988588,"version":"build-2803163510"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Cholera remains a significant public health concern in many parts of the world, particularly in areas with poor sanitation and hygiene. Bangladesh and other impoverished nations have been severely affected by cholera outbreaks, especially in areas with a high population density. In order to mitigate the spread of cholera, oral cholera vaccines (OCVs) are recommended as a prophylactic measure. In May 2018, 775,666 of the Forcibly Displaced Myanmar Nationals (FDMN) in the registered and makeshift camps and 103,605 of the residents in the host community received two doses of OCV Shanchol<jats:sup>TM<\/jats:sup> in Cox's Bazar, Bangladesh, because the conditions in the area favored the transmission of cholera and other waterborne diseases. This study aimed to assess the coverage of OCV among the FDMN and the host community in Cox's Bazar.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In August 2018, we enrolled 4,240 respondents for this study following the \u201cWorld Health Organization (WHO) Vaccination Coverage Cluster Surveys: Reference Manual (2018).\u201d The coverage survey was conducted with three strata of the population: the host community from the Teknaf Upazila, the registered camp, and the makeshift camp from the Ukhia Upazila. We collected information regarding OCV coverage, demographic characteristics, and knowledge and behaviors of people toward the vaccine. The data were analyzed using descriptive statistics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>According to our study, the overall OCV coverage was 85%, with 68% in the host community, 91% in the registered camp, and 98% in the makeshift camp. The lower coverage in the host community was due to residents unaware of the vaccination campaign, the unavailability of vaccines, and unaware where to go for vaccination.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Our findings demonstrate that the OCV campaign in the FDMN camps was successful, reaching over 90% coverage, while coverage in the host community was much lower. In order to make sure that OCV vaccination efforts are reaching the target population and having the desired impact, our study emphasizes the need to inform the target population of when and where to get vaccinated.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1147563","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T11:01:21Z","timestamp":1688554881000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Oral cholera vaccine coverage evaluation survey: Forcibly Displaced Myanmar Nationals and host community in Cox's Bazar, Bangladesh"],"prefix":"10.3389","volume":"11","author":[{"given":"Md. Omar","family":"Qayum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallick Masum","family":"Billah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ferdous Rahman","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S. M.","family":"Alamgir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehejabin","family":"Nurunnahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjur Hossain","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Salim Uzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alden","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahmina","family":"Shirin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meerjady Sabrina","family":"Flora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e0003832","DOI":"10.1371\/journal.pntd.0003832","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"Ali","year":"2015","journal-title":"PLoS Neglect Tropic Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.vaccine.2006.08.031","article-title":"Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants","volume":"25","author":"Qadri","year":"2007","journal-title":"Vaccine."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e54395","DOI":"10.1371\/journal.pone.0054395","article-title":"Risk factors for severe cholera among children under five in rural and urban bangladesh, 2000\u20132008: a hospital-based surveillance study","volume":"8","author":"Colombara","year":"2013","journal-title":"PLOS ONE."},{"key":"B4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2471\/BLT.11.093427","article-title":"The global burden of cholera","volume":"90","author":"Ali","year":"2012","journal-title":"PLOS ONE."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(22)00330-0","article-title":"Cholera","volume":"399","author":"Kanungo","year":"2022","journal-title":"Lancet (London, England)."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/S0140-6736(18)30993-0","article-title":"Emergency deployment of oral cholera vaccine for the Rohingya in Bangladesh","volume":"391","author":"Qadri","year":"2018","journal-title":"The Lancet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"A132","DOI":"10.1016\/j.vaccine.2019.08.086","article-title":"Global oral cholera vaccine use, 2013-2018","volume":"38","author":"Pezzoli","year":"2020","journal-title":"Vaccine."},{"key":"B8","unstructured":"Bangladesh:humanitarian Situation report No2018"},{"key":"B9","unstructured":"2018"},{"key":"B10","unstructured":"Bangladesh: Needs and Population Monitoring2017"},{"key":"B11","unstructured":"2017"},{"key":"B12","doi-asserted-by":"publisher","first-page":"533","DOI":"10.15585\/mmwr.mm6718a6","article-title":"Notes from the field: diarrhea and acute respiratory infection, oral cholera vaccination coverage, and care-seeking behaviors of rohingya refugees\u2014cox's bazar, bangladesh, october\u2013november","volume":"67","author":"Summers A","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B13","unstructured":"2017"},{"key":"B14","unstructured":"2018"},{"key":"B15","article-title":"\u201cShelter urgently needed for Rohingya fleeing Myanmar violence\u201d","year":"2017","journal-title":"UNHCR. United Nations High Commissioner for Refugees"},{"key":"B16","unstructured":"2017"},{"key":"B17","unstructured":"2018"},{"key":"B18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3201\/eid2301.160881","article-title":"Oral cholera vaccine coverage during an outbreak and humanitarian crisis, Iraq","volume":"23","author":"Lam","year":"2017","journal-title":"Emerg Infect Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1080\/21645515.2019.1616502","article-title":"Post-vaccination campaign coverage evaluation of oral cholera vaccine, oral polio vaccine and measles-rubella vaccine among Forcibly Displaced Myanmar Nationals in Bangladesh","volume":"15","author":"Khan","year":"2019","journal-title":"Human Vacc Immunotherapeutics."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1016\/j.vaccine.2013.10.021","article-title":"Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in <city>Dhaka <\/city>, Bangladesh","volume":"31","author":"Khan","year":"2013","journal-title":"Vaccine."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1016\/j.vaccine.2016.05.038","article-title":"Perceptions of oral cholera vaccine and reasons for full, partial and non-acceptance during a humanitarian crisis in South Sudan","volume":"34","author":"Peprah","year":"2016","journal-title":"Vaccine."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0198592","DOI":"10.1371\/journal.pone.0198592","article-title":"Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique","volume":"13","author":"Sem\u00e1 Baltazar","year":"2018","journal-title":"PLoS One."},{"key":"B23","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3201\/eid2106.141797","article-title":"Oral cholera vaccine coverage, barriers to vaccination, and adverse events following vaccination, Haiti,2013","volume":"21","author":"Tohme","year":"2015","journal-title":"Emerging Infect Dis."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1147563\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T11:01:24Z","timestamp":1688554884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1147563\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":23,"alternative-id":["10.3389\/fpubh.2023.1147563"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1147563","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"article-number":"1147563"}}